Showing results (131-140 of 457) with videos related to

Sort By:
Pageof 46
Health and Quality of Life Outcomes|May 14, 2013
Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled studyVibeke Strand, David Fiorentino, ChiaChi Hu, et al.
Arthritis Research & Therapy|May 23, 2016
Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivityJosef S Smolen, Vibeke Strand, Andrew S Koenig, et al.
Rheumatology (Oxford, England)|December 29, 2016
Analysis of haematological changes in tofacitinib-treated patients with rheumatoid arthritis across phase 3 and long-term extension studiesHendrik Schulze-Koops, Vibeke Strand, Chudy Nduaka, et al.
Rheumatology and Therapy|September 12, 2018
Local Effects Following Single and Repeat Intra-Articular Injections of Triamcinolone Acetonide Extended-Release: Results from Three Nonclinical Toxicity Studies in DogsNeil Bodick, Toni Williamson, Vibeke Strand, et al.
Health and Quality of Life Outcomes|August 8, 2023
Development and validation of a psoriasis treatment acceptability measure through group concept mappingStacie Hudgens, Amy Howerter, Shannon Keith, et al.
Arthritis Care & Research|August 27, 2016
Tofacitinib in Combination With Conventional Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient-Reported Outcomes From a Phase III Randomized Controlled TrialVibeke Strand, Joel M Kremer, David Gruben, et al.
Clinical and Experimental Rheumatology|March 5, 2015
Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2)Allan Gibofsky, Grant W Cannon, David J Harrison, et al.
Lupus Science & Medicine|November 15, 2014
Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trialsRichard Furie, Michelle A Petri, Vibeke Strand, et al.
Nature Reviews. Rheumatology|August 4, 2022
Sex- and gender-related differences in psoriatic arthritisSanjana Tarannum, Ying-Ying Leung, Sindhu R Johnson, et al.
Arthritis Research & Therapy|December 8, 2018
Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trialVibeke Strand, Evo Alemao, Thomas Lehman, et al.
Pageof 46